All lobbying filings

JIM MASSIE & PARTNERS, LLC

Lobbying for COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS · Trade association representing the radionuclide and radiopharmaceutical industry.

Filing Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Bills named in this filing 4

S 1241
Sanctioning Russia Act of 2025
HR 2548
Sanctioning Russia Act of 2025
HR 2504
The U.S.-European Nuclear Energy Cooperation Act of 2025
HR 8106
To amend title XIX of the Social Security Act to increase transparency and expand coverage options with respect to home…

Lobbying activity 2

Energy/Nuclear

Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production Legislation impacting the production and distribution of radiopharmaceuticals S.1241 - Sanctioning Russia Act of 2025 H.R. 2548 - Sanctioning Russia Act of 2025 H.R. 2504 - The U.S. - European Nuclear Energy Cooperation Act H.R. 8106 - To impose sanctions with respect to Rosatom

Trade (domestic/foreign)

Issues related to the impact of tariffs on the availability of industrial and medical isotopes.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.